Reimbursement Briefs: Express Scripts Formulary; EHR Incentives; ACA Exchanges
Executive Summary
Express Scripts estimates savings from “not covered” drug list, GAO reports statistics on electronic health record adoption incentive payments, and CMS offers status report on exchange plan applications.
You may also be interested in...
Big Data Transforming The Role Of Pharma, IBM Analytics Partner Says
Pharmaceutical companies are beginning to leverage big data to become more integrated into health care delivery, looking to care coordination and other “services adjacent to medicines,” IBM’s John Piccone reports.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.